Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia

摘要

Background and objectiveCurrent guidelines recommend empirical treatment against Pseudomonas aeruginosa in community-acquired pneumonia (CAP) patients with specific risk factors. However, evidence to support these recommendations is limited. We evaluate the risk factors and the impact of antimicrobial therapy in patients hospitalized with CAP due to P.aeruginosa.